Chemclin Diagnostics Co. Ltd. A - Asset Resilience Ratio

Latest as of September 2025: 12.14%

Chemclin Diagnostics Co. Ltd. A (688468) has an Asset Resilience Ratio of 12.14% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 688468 liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥215.00 Million

≈ $31.46 Million USD Cash + Short-term Investments

Total Assets

CN¥1.77 Billion

≈ $259.26 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2024)

This chart shows how Chemclin Diagnostics Co. Ltd. A's Asset Resilience Ratio has changed over time. See Chemclin Diagnostics Co. Ltd. A net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Chemclin Diagnostics Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 688468 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥215.00 Million	12.14%
Total Liquid Assets	CN¥215.00 Million	12.14%

Asset Resilience Insights

Moderate Liquidity: Chemclin Diagnostics Co. Ltd. A has 12.14% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Chemclin Diagnostics Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Chemclin Diagnostics Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Eurofins-Cerep SA PA:ALECR	Diagnostics & Research	6.56%
Inoviq Ltd AU:IIQ	Diagnostics & Research	56.29%
Bcal Diagnostics Ltd AU:BDX	Diagnostics & Research	0.00%
Imagion Biosystems Ltd AU:IBX	Diagnostics & Research	150.16%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%

Annual Asset Resilience Ratio for Chemclin Diagnostics Co. Ltd. A (2019–2024)

The table below shows the annual Asset Resilience Ratio data for Chemclin Diagnostics Co. Ltd. A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	27.78%	CN¥509.00 Million ≈ $74.48 Million	CN¥1.83 Billion ≈ $268.10 Million	+1.97pp
2023-12-31	25.82%	CN¥470.00 Million ≈ $68.78 Million	CN¥1.82 Billion ≈ $266.41 Million	-14.59pp
2022-12-31	40.41%	CN¥643.00 Million ≈ $94.09 Million	CN¥1.59 Billion ≈ $232.84 Million	-2.43pp
2021-12-31	42.84%	CN¥613.00 Million ≈ $89.70 Million	CN¥1.43 Billion ≈ $209.39 Million	+10.21pp
2020-12-31	32.63%	CN¥328.57 Million ≈ $48.08 Million	CN¥1.01 Billion ≈ $147.33 Million	-15.68pp
2019-12-31	48.32%	CN¥480.00 Million ≈ $70.24 Million	CN¥993.39 Million ≈ $145.36 Million	--

pp = percentage points

About Chemclin Diagnostics Co. Ltd. A

SHG:688468 China Diagnostics & Research

Market Cap

$439.62 Million

CN¥3.00 Billion CNY

Market Cap Rank

#13220 Global

#4156 in China

Share Price

CN¥7.49

Change (1 day)

+1.08%

52-Week Range

CN¥6.79 - CN¥8.94

All Time High

CN¥27.99